Characterization of the Ala62Pro polymorphic variant of human cytochrome P450 1A1 using recombinant protein expression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seung Heon | - |
dc.contributor.author | Kang, Sukmo | - |
dc.contributor.author | Dong, Mi Sook | - |
dc.contributor.author | Park, Jung-Duck | - |
dc.contributor.author | Park, Jinseo | - |
dc.contributor.author | Rhee, Sangkee | - |
dc.contributor.author | Ryu, Doug-Young | - |
dc.date.available | 2019-03-08T17:01:01Z | - |
dc.date.issued | 2015-06 | - |
dc.identifier.issn | 0041-008X | - |
dc.identifier.issn | 1096-0333 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/9443 | - |
dc.description.abstract | Cytochrome P450 (CYP) 1A1 is a heme-containing enzyme involved in detoxification of hydrophobic pollutants. Its Ala62Pro variant has been identified previously. Ala62 is located in a-helix A of CYP1A1. Residues such as Pro and Gly are a-helix breakers. In this study, the Ala62Pro variant was characterized using heterologous expression. E. coli expressing the Ala62Pro variant, and the purified variant protein, had lower CYP (i.e. holoenzyme) contents than their wild-type (WT) equivalents. The CYP variant from E. coli and mammalian cells exhibited lower 7-ethoxyresorufin O-dealkylation (EROD) and benzo[a]pyrene hydroxylation activities than the WT. Enhanced supplementation of a heme precursor during E. coli culture did not increase CYP content in E. coli expressing the variant but did for the WT. As for Ala62Pro, E. coli expressing an Ala62Gly variant had a lower CYP content than the WT counterpart, but substitution of Ala62 with a-helix-compatible residues such as Ser and Val partially recovered the level of CYP produced. Microsomes from mammalian cells expressing Ala62Pro and Ala62Gly variants exhibited lower EROD activities than those expressing the WT or Ala62Val variant. A region harboring a-helix A has interactions with another region containing heme-interacting residues. Site-directed mutagenesis analyses suggest the importance of interactions between the two regions on holoenzyme expression. Together, these findings suggest that the Ala62Pro substitution leads to changes in protein characteristics and function of CYP1A1 via structural disturbance of the region where the residue is located. (C) 2015 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.title | Characterization of the Ala62Pro polymorphic variant of human cytochrome P450 1A1 using recombinant protein expression | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.taap.2015.04.010 | - |
dc.identifier.bibliographicCitation | TOXICOLOGY AND APPLIED PHARMACOLOGY, v.285, no.3, pp 159 - 169 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000355242000002 | - |
dc.identifier.scopusid | 2-s2.0-84928710677 | - |
dc.citation.endPage | 169 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 159 | - |
dc.citation.title | TOXICOLOGY AND APPLIED PHARMACOLOGY | - |
dc.citation.volume | 285 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | CYP1A1 | - |
dc.subject.keywordAuthor | CYP1A1*12 | - |
dc.subject.keywordAuthor | alpha-helix | - |
dc.subject.keywordAuthor | Home | - |
dc.subject.keywordAuthor | Protein structure | - |
dc.subject.keywordAuthor | Enzyme activity | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | MICROSOMAL CYTOCHROME-P-450 | - |
dc.subject.keywordPlus | ENZYMATIC-ACTIVITY | - |
dc.subject.keywordPlus | P450 SUPERFAMILY | - |
dc.subject.keywordPlus | MEANDER REGION | - |
dc.subject.keywordPlus | HEME-BINDING | - |
dc.subject.keywordPlus | HUMAN CYP1A1 | - |
dc.subject.keywordPlus | PURIFICATION | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | ACID | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.